ALKS
Alkermes plc
Stock NASDAQ – Stock Market Prices, News & Analysis
Alkermes is a biopharmaceutical company focused on developing therapeutic innovations for chronic diseases, particularly in the fields of psychiatry and oncology.
Alkermes plc
ALKS
Alkermes is a biopharmaceutical company focused on developing therapeutic innovations for chronic diseases, particularly in the fields of psychiatry and oncology.
Price history of Alkermes plc
Price history of Alkermes plc
Performance & Momentum
Strategic Analysis
Alkermes plc • 2026
Alkermes is positioned as an innovative player in the American biopharmaceutical sector, specializing in the treatment of chronic diseases with a particular focus on psychiatry and oncology. Its model is based on the targeted development of high-value niche therapies, combining advanced research and differentiated therapeutic approaches.
Strengths
- Recognized expertise in the complex and high medical need areas of psychiatry and oncology
- Product portfolio in development focused on demanding chronic conditions
- Strong therapeutic innovation capability in a competitive biotechnology sector
Weaknesses
- High sensitivity to clinical outcomes and regulatory decisions
- Financial resources dependent on the success of advanced development stages
Momentum
The current momentum indicates a moderate dynamic with stable performance over the medium term. The absence of recent news reinforces a stable profile but necessitates vigilance regarding the evolution of pipeline projects to consider potential for rebound or consolidation.
Similar stocks to Alkermes plc
Take control
of your investments
Track your portfolios, analyze your performance and receive personalized insights to invest with strategy.
- Real-time multi-portfolio tracking
- AI analysis of your positions
- Counter your cognitive biases
